1 2 

Advancing the success of emerging health technologies to save and improve lives globally.

KMT Hepatech, Inc., a part of PhoenixBio group, announced plans to expand staff and operations by providing services with PXB-Mouse® and starting the production of the PXB-Cells® – hepatocytes isolated from cDNA-uPA/SCID mice with highly humanized liver.

ViaGen has been cloning livestock for more than 15 years, and have recently turned their attention to cloning dogs and cats.

Genomics testing is now practical for crossbred herds, says Delta Genomics.

Cielo Announces a Significant Transaction as it Closes its Previously Announced $3.5M Credit Facility to Fund Renewable Diesel Refinery.

Thursday, November 16, 2017

... carry hidden costs, "Research, innovation goals could be adversely affected." says Mel Wong, BioAlberta's President & CEO.

New biotech spinoff with roots in a GlycoNet project is planning to capitalize on the discovery of a novel cancer-specific sugar to develop new diagnostic tools and drugs for prostate cancer.

Aquila Diagnostics is pleased to announce results of an independent laboratory trial for its
point-of-care AccutasVET Tapeworm DNA test.

Thursday, November 16, 2017

KMT Hepatech announces strategic investment from PhoenixBio to join forces to advance the use of a mouse model with highly humanized liver.

Ceapro announced its entry into the end-user cosmeceuticals market through the acquisition of Quebec-based company, JuventeDC Inc.

Legislation creating two credits: CITC & AITC will support at least 9,000 jobs and add $1.2 billion to Alberta’s GDP.

Botaneco Inc. was recently named the Alberta Bioindustry "Company of the Year." The award was presented to President and CEO, James Szarko, at the BioAlberta Achievement Awards Gala.

GlycoNet announces agreement with start-up 48Hour Discovery EDMONTON (October 19)

Edmonton-based BioNeutra is a 2017 Finalist for ASTech Awards for Science and Technology. The company takes a unique approach to trying to help solve this global healthcare problem with a low calorie, natural sweetener: VitaFiber™ .

BioAlberta Recognizes Alberta Innovators and Entrepreneurs at 2017 AGM and Awards Gala in Edmonton.

This research unit designs and performs pragmatic trials and research projects that harness the power of real-world health data.

A New Approach to Treating Obstructive Sleep Apnea: Zephyr Sleep Technologies Strikes Strategic Partnership with Dentsply Sirona.

First Patient Enrolled in OncoQuest’s Phase 1/2 Study Combining Oregovomab with Hiltonol® in Recurrent Ovarian Cancer.

Wednesday, July 19, 2017

Quest PharmaTech Inc., an Edmonton-based pharmaceutical company, announce the appointment of Mark Lievonen, to the
company's Board of Directors.

Exciton Technologies Receives Approval from China Food and Drug Administration

Licensing agreement will ensure MMDx becomes the standard of care for transplant patients.

New partnerships with the University Hospital Foundation and leading pharmaceutical companies, Servier and Merck, will help dozens of Alberta health innovators market their discoveries to the world.

Edmonton’s General Intermediates of Canada Inc. (GIC) announced they have successfully completed a research project related to a key starting API material for a global pharmaceutical client.

Yesterday the innovative pharmaceutical industry and the Government of Alberta solidified a collaboration to ignite the life sciences sector in Alberta.

1 2